tiprankstipranks
Trending News
More News >
Clal Biotechnology Industries Ltd (IL:CBI)
:CBI
Israel Market
Advertisement

Clal Biotech (CBI) Financial Statements

Compare
0 Followers

Clal Biotech Financial Overview

Clal Biotech's market cap is currently 47.99M. The company's EPS TTM is -0.397; its P/E ratio is ―; Clal Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue 104.00K 370.00K 76.96M 74.54M 113.29M
Gross Profit 104.00K 370.00K 10.72M 6.22M 55.39M
Operating Income -10.18M 100.61M -101.20M -83.64M -79.86M
EBITDA -24.02M 64.22M -78.69M 13.23M -58.84M
Net Income -31.05M -61.74M -89.58M 109.03M -154.11M
Balance Sheet
Cash & Short-Term Investments 13.36M 12.88M 53.05M 186.50M 114.53M
Total Assets 158.39M 182.69M 444.92M 614.03M 616.97M
Total Debt 35.76M 9.34M 11.68M 7.74M 19.91M
Net Debt 30.03M 1.90M -41.37M -60.42M -17.65M
Total Liabilities 36.98M 37.79M 106.55M 100.24M 119.12M
Stockholders' Equity 99.36M 126.03M 172.59M 306.35M 223.60M
Cash Flow
Free Cash Flow -8.52M -60.31M -42.92M -36.41M 24.20M
Operating Cash Flow -8.51M -59.04M -41.33M -33.23M 27.03M
Investing Cash Flow 7.66M -10.96M 79.18M 70.78M -23.52M
Financing Cash Flow -1.18M 20.05M -51.54M -2.38M -2.52M
Currency in ILS

Clal Biotech Earnings and Revenue History

Clal Biotech Debt to Assets

Clal Biotech Cash Flow

Clal Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis